Teladoc Health, Inc.

TDOC

Teladoc Health, Inc.

TDOC

Insider Sentiment (TTM):

Last Purchase:2025-11-14Last Sale:2026-06-29Shares Purchased (TTM):10,000Shares Sold (TTM):343,508

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:140,449,778Shares Outstanding:179,122,268Institutional Ownership Pct.:78.41%

Earnings Market Reaction:

Filing Date:2026-04-30Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Offices & Clinics of Doctors of Medicine

HIMS SBC TOI AIRS LFMD CDIX

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	751	781	726	680	1,193	1,298	1,244	1,162	1,098	1,124	1,031	959
Accounts Receivable Net Current	214	193	211	225	233	214	212	218	214	217	206	215
Inventory Net	32	38	40	38	38	38	37	35	32	30	36	34
Prepaid Expense And Other Assets Current	136	107	116	130	138	113	116	131	142	118	115	113
Assets Current	1,132	1,119	1,093	1,073	1,602	1,664	1,609	1,547	1,486	1,489	1,387	1,321
Property Plant And Equipment Net	26	27	27	28	31	29	28	29	30	32	33	30
Goodwill	283	283	283	283	283	283	283	283	1,073	1,073	1,073	1,073
Intangible Assets Net Excluding Goodwill	1,235	1,297	1,337	1,383	1,393	1,431	1,497	1,547	1,614	1,678	1,728	1,784
Operating Lease Right Of Use Asset	24	26	32	26	27	27	34	36	38	40	32	35
Other Assets Noncurrent	106	106	107	101	109	81	78	81	80	80	74	73
Assets	2,807	2,858	2,879	2,894	3,444	3,517	3,529	3,524	4,321	4,392	4,328	4,316
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	45	48	52	54	52	33	38	56	38	44	26	16
Employee Related Liabilities Current	61	96	77	70	57	76	66	55	51	103	85	67
Contract With Customer Liability Current	66	62	70	75	74	79	88	95	101	96	99	107
Convertible Debt Current	-	0	0	0	551	551	551	551	-	0	-	-
Liabilities Current	405	405	405	402	952	942	931	931	389	421	403	383
Operating Lease Liability Noncurrent	32	34	38	32	34	32	37	38	40	43	34	37
Contract With Customer Liability Noncurrent	10	9	11	11	10	10	10	12	15	14	13	14
Deferred Income Tax Liabilities Net	28	29	34	30	24	50	51	51	47	49	44	48
Convertible Debt Noncurrent	996	995	994	993	992	991	991	990	1,540	1,539	1,538	1,537
Other Liabilities Noncurrent	1	1	4	4	4	1	1	1	1	1	2	2
Liabilities	1,471	1,473	1,486	1,472	2,017	2,025	2,021	2,022	-	2,066	-	-
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	17,866	17,850	17,832	17,813	17,787	17,759	17,726	17,689	17,638	17,592	17,535	17,476
Retained Earnings Accumulated Deficit	-16,494	-16,430	-16,405	-16,356	-16,323	-16,230	-16,181	-16,148	-15,311	-15,229	-15,200	-15,143
Accumulated Other Comprehensive Income Loss Net Of…	-35	-35	-35	-35	-37	-38	-37	-39	-39	-37	-42	-39
Stockholders Equity	1,336	1,386	1,392	1,422	1,427	1,491	1,508	1,502	2,289	2,326	2,294	2,295
Liabilities And Stockholders Equity	2,807	2,858	2,879	2,894	3,444	3,517	3,529	3,524	4,321	4,392	4,328	4,316
Allowance For Doubtful Accounts Receivable Current	3	4	4	5	5	5	4	4	4	4	8	8
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Common Stock Shares Issued	180	178	177	177	175	173	172	171	169	167	166	165
Shares Outstanding	180	178	177	177	175	173	172	171	169	167	166	165

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	8.42%	33.17%	55.61%	-	-	-	-	-	-	-	-	-
2025	-2.58%	-1.29%	15.16%	3.78%	7.43%	15.27%	-20.37%	-17.28%	-28.15%	0.00%	6.36%	18.88%
2024	-2.15%	-23.14%	-27.82%	-13.62%	1.86%	14.55%	18.00%	4.89%	1.00%	-11.47%	-28.11%	-20.84%
2023	-12.87%	-8.80%	-9.76%	-18.22%	-24.98%	-34.50%	10.28%	31.79%	34.04%	4.28%	-2.00%	-17.59%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	2.80	2.77	2.70	2.67	1.68	1.77	1.73	1.66	3.82	3.54	3.44	3.45
Quick Ratio	2.38	2.41	2.31	2.25	1.50	1.61	1.56	1.48	3.37	3.19	3.07	3.06
Working Capital	727.47M	714.39M	687.67M	671.50M	649.41M	722.37M	677.26M	615.93M	1.10B	1.07B	984.45M	937.57M
Leverage & Debt
Debt to Equity	1.10	1.06	1.07	1.03	1.41	1.36	1.34	1.35	0.17	0.89	0.18	0.17
Interest Coverage TTM	-10.57	-13.34	-12.73	-11.77	-44.08	-42.89	-44.80	-45.73	-11.41	-11.15	-149.35	-146.87
Debt Ratio	0.52	0.52	0.52	0.51	0.59	0.58	0.57	0.57	0.09	0.47	0.09	0.09
Efficiency & Turnover
Asset Turnover TTM	0.80	0.79	0.79	0.79	0.66	0.65	0.66	0.67	0.61	0.60	0.41	0.41
Days Sales Outstanding TTM	32.41	29.36	30.52	31.86	31.97	30.65	29.45	30.33	29.98	30.01	28.83	30.33
Receivables Turnover TTM	11.26	12.43	11.96	11.46	11.42	11.91	12.39	12.04	12.18	12.16	12.66	12.03
Per Share Metrics
Diluted EPS TTM	-0.96	-1.14	-1.26	-1.18	-5.81	-5.87	-5.72	-5.91	-1.39	-1.34	-24.23	-24.47
Free Cash Flow Per Share TTM	1.56	1.62	1.58	1.66	1.66	1.66	1.93	1.90	2.00	2.06	1.63	1.39
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	69.29%	69.50%	69.80%	70.26%	70.48%	70.76%	70.82%	70.80%	70.81%	70.80%	70.71%	70.16%
Operating Profit Margin TTM	-8.12%	-10.39%	-10.88%	-10.53%	-41.30%	-39.73%	-38.92%	-39.40%	-9.87%	-9.55%	-156.19%	-159.48%
Net Profit Margin TTM	-6.81%	-7.92%	-8.84%	-8.16%	-39.66%	-38.97%	-37.91%	-38.54%	-8.90%	-8.47%	-155.12%	-158.76%
Growth Metrics
Net Revenue Growth (1Y)	-1.50%	-1.54%	-2.37%	-2.57%	-2.54%	-1.26%	0.39%	3.10%	6.01%	8.13%	11.03%	13.30%
Net Income Growth (1Y)	-83.09%	-79.99%	-77.23%	-79.38%	334.44%	354.35%	-75.47%	-74.97%	-96.70%	-98.39%	-59.42%	-59.30%
EPS Growth (1Y)	-83.56%	-80.64%	-77.93%	-80.04%	318.42%	338.41%	-76.38%	-75.86%	-96.79%	-98.42%	-60.25%	-59.99%
Valuation Metrics
P/E TTM	-5.70	-6.16	-6.12	-7.39	-1.37	-1.55	-1.60	-1.66	-10.87	-16.09	-0.77	-1.03
P/B TTM	0.73	0.89	0.98	1.08	0.97	1.04	1.04	1.11	1.11	1.52	1.34	1.81
P/S TTM	0.39	0.49	0.54	0.60	0.54	0.60	0.61	0.64	0.97	1.36	1.19	1.64
Market Cap	976.22M	1.23B	1.37B	1.53B	1.39B	1.55B	1.57B	1.66B	2.53B	3.55B	3.07B	4.16B
Enterprise Value	1.22B	1.45B	1.64B	1.85B	1.74B	1.79B	1.87B	2.04B	2.97B	3.96B	3.58B	4.74B
Calculated Values
Free Cash Flow TTM	280.13M	285.46M	280.11M	291.71M	288.31M	282.89M	331.80M	323.03M	335.54M	338.56M	269.23M	228.62M
Net Debt	245.07M	213.84M	267.80M	313.54M	349.68M	243.81M	297.41M	378.03M	441.61M	415.01M	507.31M	578.29M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-29Sale

Owner: Bliss, Kelly

Title: President, U.S. Group Health

Shares: 2,500

Price/Share: $8.50

Value: $21,250.00

Shares Owned: 89,878

Relationship: Officer

Ownership: Direct

2026-06-11Sale

Owner: Divita, Charles Iii

Title: CHIEF EXECUTIVE OFFICER

Shares: 18,074

Price/Share: $6.94

Value: $125,433.56

Shares Owned: 414,622

Relationship: Director,Officer

Ownership: Direct

2026-06-03Sale

Owner: Rodrigues, Fernando M.

Title: President of BetterHelp

Shares: 9,572

Price/Share: $7.40

Value: $70,832.80

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-06-02Sale

Owner: Catapano, Joseph Ronald

Title: Chief Accounting Officer

Shares: 284

Price/Share: $7.63

Value: $2,166.92

Shares Owned: 10,837

Relationship: Officer

Ownership: Direct

2026-06-02Sale

Owner: Nueno, Carlos

Title: President, International

Shares: 6,196

Price/Share: $7.63

Value: $47,275.48

Shares Owned: 57,671

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-29	Bliss, Kelly	Officer	President, U.S. Group Health	Direct	Sale	2,500	8.50	$21,250.00	89,878	4
2026-06-11	Divita, Charles Iii	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	18,074	6.94	$125,433.56	414,622	4
2026-06-03	Rodrigues, Fernando M.	Officer	President of BetterHelp	Direct	Sale	9,572	7.40	$70,832.80	0	4
2026-06-02	Catapano, Joseph Ronald	Officer	Chief Accounting Officer	Direct	Sale	284	7.63	$2,166.92	10,837	4
2026-06-02	Nueno, Carlos	Officer	President, International	Direct	Sale	6,196	7.63	$47,275.48	57,671	4
2026-06-02	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	7,906	7.63	$60,322.78	110,261	4
2026-06-02	Rodrigues, Fernando M.	Officer	President of BetterHelp	Direct	Sale	5,677	7.63	$43,315.51	9,572	4
2026-06-02	Divita, Charles Iii	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	19,132	7.63	$145,977.16	389,894	4
2026-06-02	Bliss, Kelly	Officer	President, U.S. Group Health	Direct	Sale	7,679	7.63	$58,590.77	92,378	4
2026-04-02	Catapano, Joseph Ronald	Officer	Chief Accounting Officer	Direct	Sale	675	5.11	$3,449.25	10,249	4
2026-03-11	Divita, Charles Iii	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	27,731	5.49	$152,243.19	364,784	4
2026-03-03	Rodrigues, Fernando M.	Officer	President of BetterHelp	Direct	Sale	25,086	4.98	$124,928.28	0	4
2026-03-02	Bliss, Kelly	Officer	President, U.S. Group Health	Direct	Sale	26,647	5.12	$136,432.64	84,747	4
2026-03-02	Nueno, Carlos	Officer	President, International	Direct	Sale	20,165	5.12	$103,244.80	50,595	4
2026-03-02	Catapano, Joseph Ronald	Officer	Chief Accounting Officer	Direct	Sale	1,333	5.12	$6,824.96	8,841	4
2026-03-02	Divita, Charles Iii	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	50,145	5.12	$256,742.40	327,862	4
2026-03-02	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	27,083	5.12	$138,664.96	103,239	4
2026-01-05	Catapano, Joseph Ronald	Officer	Chief Accounting Officer	Direct	Sale	758	7.15	$5,419.70	6,686	4
2025-12-11	Divita, Charles Iii	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	17,138	7.63	$130,762.94	201,036	4
2025-12-03	Rodrigues, Fernando M.	Officer	President of BetterHelp	Direct	Sale	4,209	7.48	$31,483.32	0	4
2025-12-02	Bliss, Kelly	Officer	President, U.S. Group Health	Direct	Sale	4,582	7.49	$34,319.18	60,054	4
2025-12-02	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	5,720	7.49	$42,842.80	80,732	4
2025-12-02	Nueno, Carlos	Officer	President, International	Direct	Sale	3,897	7.49	$29,188.53	27,175	4
2025-11-14	Paulus, Kenneth H	Director	-	Direct	Purchase	10,000	6.94	$69,400.00	10,000	4
2025-10-02	Catapano, Joseph Ronald	Officer	Chief Accounting Officer	Direct	Sale	2,972	7.89	$23,449.08	5,361	4
2025-09-11	Divita, Charles Iii	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	16,787	7.59	$127,413.33	179,014	4
2025-09-03	Rodrigues, Fernando M.	Officer	President of BetterHelp	Direct	Sale	4,149	7.59	$31,490.91	0	4
2025-09-02	Bliss, Kelly	Officer	President, U.S. Group Health	Direct	Sale	4,700	7.59	$35,673.00	55,101	4
2025-09-02	Murthy, Mala	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	12,846	7.59	$97,501.14	142,385	4
2025-09-02	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	5,867	7.59	$44,530.53	75,179	4
2025-09-02	Nueno, Carlos	Officer	President, International	Direct	Sale	3,998	7.59	$30,344.82	22,359	4
2025-06-03	Rodrigues, Fernando M.	Officer	President of BetterHelp	Direct	Sale	4,174	6.91	$28,842.34	0	4
2025-06-02	Murthy, Mala	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	13,856	6.86	$95,052.16	132,443	4
2025-06-02	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	5,808	6.86	$39,842.88	69,773	4
2025-06-02	Nueno, Carlos	Officer	President, International	Direct	Sale	3,958	6.86	$27,151.88	17,645	4
2025-06-02	Bliss, Kelly	Officer	President, U.S. Group Health	Direct	Sale	4,653	6.86	$31,919.58	50,266	4
2025-04-07	Murthy, Mala	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	7,494	6.81	$51,034.14	121,467	4
2025-03-21	Rodrigues, Fernando M.	Officer	President of BetterHelp	Direct	Sale	2,663	8.00	$21,304.00	0	4
2025-03-20	Bliss, Kelly	Officer	President, U.S. Group Health	Direct	Sale	9,470	8.42	$79,737.40	45,384	4
2025-03-20	Murthy, Mala	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	20,586	8.42	$173,334.12	116,309	4
2025-03-20	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	11,011	8.42	$92,712.62	64,308	4
2025-03-20	Nueno, Carlos	Officer	President, International	Direct	Sale	8,266	8.42	$69,599.72	12,891	4
2025-03-05	Rodrigues, Fernando M.	Officer	President of BetterHelp	Direct	Sale	3,558	9.20	$32,733.60	0	4
2025-03-03	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	3,935	9.68	$38,090.80	53,919	4
2025-03-03	Nueno, Carlos	Officer	President, International	Direct	Sale	2,347	9.68	$22,718.96	2,932	4
2025-03-03	Rodrigues, Fernando M.	Officer	President of BetterHelp	Direct	Sale	1,933	9.68	$18,711.44	3,558	4
2025-03-03	Bliss, Kelly	Officer	President, U.S. Group Health	Direct	Sale	2,904	9.68	$28,110.72	35,421	4
2025-03-03	Murthy, Mala	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	8,630	9.68	$83,538.40	99,962	4
2024-12-03	Rodrigues, Fernando M.	Officer	President of BetterHelp	Direct	Sale	14,091	11.07	$155,987.37	0	4
2024-12-03	Nueno, Carlos	Officer	President, International	Direct	Sale	2,890	11.23	$32,454.70	0	4
2024-12-02	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	4,004	11.93	$47,767.72	50,050	4
2024-12-02	Murthy, Mala	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	8,783	11.93	$104,781.19	92,788	4
2024-12-02	Bliss, Kelly	Officer	President, U.S. Group Health	Direct	Sale	2,040	11.93	$24,337.20	32,244	4
2024-10-02	Bliss, Kelly	Officer	President, U.S. Group Health	Direct	Sale	897	8.68	$7,785.96	28,203	4
2024-09-12	Mckinley, Thomas	Director	-	Direct	Purchase	4,000	7.69	$30,760.00	39,077	4
2024-09-04	Turitz, Andrew	Officer	EVP, CORPORATE DEVELOPMENT	Direct	Sale	20,773	7.26	$150,811.98	20,773	4
2024-09-04	Raman-Tangella, Vidya	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	468	7.26	$3,397.68	33,665	4
2024-09-03	Geshuri, Arnnon	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	1,795	7.16	$12,852.20	44,914	4
2024-09-03	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	2,817	7.16	$20,169.72	46,250	4
2024-09-03	Raman-Tangella, Vidya	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	1,114	7.16	$7,976.24	34,133	4
2024-09-03	Murthy, Mala	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	8,750	7.16	$62,650.00	85,767	4
2024-09-03	Nanis, Nikolaos P.	Officer	Chief Technology Officer	Direct	Sale	1,033	7.16	$7,396.28	75,410	4
2024-09-03	Cave, James L.	Officer	INTERIM CAO	Direct	Sale	555	7.16	$3,973.80	13,808	4
2024-09-03	Waters, Michael Willem	Officer	CHIEF OPERATING OFFICER	Direct	Sale	4,218	7.16	$30,200.88	78,309	4
2024-09-03	Verstraete, Stephany	Officer	CHIEF MARKETING OFFICER	Direct	Sale	2,083	7.16	$14,914.28	48,843	4
2024-09-03	Turitz, Andrew	Officer	EVP, CORPORATE DEVELOPMENT	Direct	Sale	1,617	7.16	$11,577.72	41,546	4
2024-09-03	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,777	7.16	$12,723.32	31,465	4
2024-08-15	Smith, Mark Douglas	Director	-	Direct	Purchase	4,000	7.08	$28,320.00	8,355	4
2024-08-12	Nanis, Nikolaos P.	Officer	Chief Technology Officer	Direct	Sale	206	7.14	$1,470.84	73,588	4
2024-08-07	Verstraete, Stephany	Officer	CHIEF MARKETING OFFICER	Direct	Sale	15,000	7.60	$114,000.00	45,158	4
2024-08-07	Mckinley, Thomas	Director	-	Direct	Purchase	4,000	7.19	$28,760.00	35,077	4
2024-08-05	Raman-Tangella, Vidya	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	1,537	7.33	$11,266.21	32,130	4
2024-08-02	Raman-Tangella, Vidya	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	3,857	8.14	$31,395.98	33,667	4
2024-08-02	Waters, Michael Willem	Officer	CHIEF OPERATING OFFICER	Direct	Sale	6,053	8.14	$49,271.42	74,214	4
2024-08-02	Kornwasser, Laizer	Officer	Advisor to the CEO	Direct	Sale	10,879	8.14	$88,555.06	99,929	4
2024-07-02	Nanis, Nikolaos P.	Officer	Chief Technology Officer	Direct	Sale	442	9.39	$4,150.38	73,226	4
2024-06-04	Raman-Tangella, Vidya	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	468	11.04	$5,166.72	27,280	4
2024-06-03	Geshuri, Arnnon	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	1,807	11.16	$20,166.12	41,686	4
2024-06-03	Kornwasser, Laizer	Officer	PRESIDENT, ENTERPRISE GROWTH	Direct	Sale	4,812	11.16	$53,701.92	90,610	4
2024-06-03	Murthy, Mala	Officer	ACTING CEO, CFO	Direct	Sale	8,807	11.16	$98,286.12	78,713	4
2024-06-03	Turitz, Andrew	Officer	EVP, CORPORATE DEVELOPMENT	Direct	Sale	1,627	11.16	$18,157.32	37,659	4
2024-06-03	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	4,015	11.16	$44,807.40	41,264	4
2024-06-03	Verstraete, Stephany	Officer	CHIEF MARKETING OFFICER	Direct	Sale	2,096	11.16	$23,391.36	60,158	4
2024-06-03	Nanis, Nikolaos P.	Officer	Chief Technology Officer	Direct	Sale	1,040	11.16	$11,606.40	72,435	4
2024-06-03	Cave, James L.	Officer	INTERIM CAO	Direct	Sale	854	11.16	$9,530.64	12,479	4
2024-06-03	Waters, Michael Willem	Officer	CHIEF OPERATING OFFICER	Direct	Sale	4,246	11.16	$47,385.36	68,948	4
2024-06-03	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,790	11.16	$19,976.40	28,322	4
2024-05-23	Daniel, Karen L	Director	-	Direct	Sale	9,834	11.90	$117,024.60	36,995	4
2024-05-17	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,000	12.83	$12,830.00	25,192	4
2024-05-02	Kornwasser, Laizer	Officer	PRESIDENT, ENTERPRISE GROWTH	Direct	Sale	10,411	12.69	$132,115.59	86,070	4
2024-05-02	Waters, Michael Willem	Officer	CHIEF OPERATING OFFICER	Direct	Sale	5,793	12.69	$73,513.17	64,881	4
2024-05-02	Raman-Tangella, Vidya	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	3,691	12.69	$46,838.79	29,160	4
2024-04-17	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,000	13.21	$13,210.00	26,192	4
2024-04-02	Nanis, Nikolaos P.	Officer	Chief Technology Officer	Direct	Sale	461	14.31	$6,596.91	70,621	4
2024-03-25	Geshuri, Arnnon	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	7,500	15.06	$112,950.00	38,470	4
2024-03-18	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,000	15.18	$15,180.00	27,192	4
2024-03-05	Turitz, Andrew	Officer	EVP, CORPORATE DEVELOPMENT	Direct	Sale	5,647	14.53	$82,050.91	33,782	4
2024-03-04	Geshuri, Arnnon	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	6,108	14.52	$88,688.16	38,470	4
2024-03-04	Waters, Michael Willem	Officer	CHIEF OPERATING OFFICER	Direct	Sale	12,468	14.52	$181,035.36	59,355	4
2024-03-04	Murthy, Mala	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	29,888	14.52	$433,973.76	71,716	4
2024-03-04	Napolitano, Richard J	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	3,765	14.52	$54,667.80	18,077	4
2024-03-04	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	15,653	14.52	$227,281.56	37,476	4
2024-03-04	Verstraete, Stephany	Officer	CHIEF MARKETING OFFICER	Direct	Sale	7,945	14.52	$115,361.40	56,486	4
2024-03-04	Turitz, Andrew	Officer	EVP, CORPORATE DEVELOPMENT	Direct	Sale	6,190	14.52	$89,878.80	39,429	4
2024-03-04	Gorevic, Jason N	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	53,755	14.52	$780,522.60	653,073	4
2024-03-04	Nanis, Nikolaos P.	Officer	Chief Technology Officer	Direct	Sale	2,866	14.52	$41,614.32	69,850	4
2024-03-04	Raman-Tangella, Vidya	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	4,599	14.52	$66,777.48	22,607	4
2024-03-04	Kornwasser, Laizer	Officer	PRESIDENT, ENTERPRISE GROWTH	Direct	Sale	18,349	14.52	$266,427.48	76,283	4
2024-03-04	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	6,780	14.52	$98,445.60	28,192	4
2024-02-26	Geshuri, Arnnon	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	404	14.50	$5,858.00	28,020	4
2024-02-20	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,000	20.64	$20,640.00	16,788	4
2024-02-02	Raman-Tangella, Vidya	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	4,128	19.18	$79,175.04	14,737	4
2024-02-02	Napolitano, Richard J	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	872	19.18	$16,724.96	11,749	4
2024-02-02	Kornwasser, Laizer	Officer	PRESIDENT, ENTERPRISE GROWTH	Direct	Sale	7,882	19.18	$151,176.76	57,223	4
2024-02-02	Waters, Michael Willem	Officer	CHIEF OPERATING OFFICER	Direct	Sale	4,523	19.18	$86,751.14	38,570	4
2024-01-17	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,000	19.46	$19,460.00	17,788	4
2024-01-03	Nanis, Nikolaos P.	Officer	Chief Technology Officer	Direct	Sale	520	21.36	$11,107.20	65,031	4
2023-12-26	Raman-Tangella, Vidya	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	27,310	22.00	$600,820.00	8,621	4
2023-12-20	Daniel, Karen L	Director	-	Direct	Sale	14,073	21.41	$301,302.93	36,995	4
2023-12-18	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,000	20.36	$20,360.00	18,788	4
2023-12-04	Geshuri, Arnnon	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	410	18.90	$7,749.00	28,424	4
2023-12-04	Nanis, Nikolaos P.	Officer	Chief Technology Officer	Direct	Sale	508	18.90	$9,601.20	64,319	4
2023-12-04	Napolitano, Richard J	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	652	18.90	$12,322.80	10,601	4
2023-12-04	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	965	18.90	$18,238.50	23,467	4
2023-12-04	Murthy, Mala	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,004	18.90	$56,775.60	49,315	4
2023-12-04	Turitz, Andrew	Officer	EVP, CORPORATE DEVELOPMENT	Direct	Sale	397	18.90	$7,503.30	25,668	4
2023-12-04	Gorevic, Jason N	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	2,877	18.90	$54,375.30	601,734	4
2023-12-04	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	427	18.90	$8,070.30	19,788	4
2023-12-04	Verstraete, Stephany	Officer	CHIEF MARKETING OFFICER	Direct	Sale	509	18.90	$9,620.10	43,117	4
2023-11-27	Geshuri, Arnnon	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	346	17.04	$5,895.84	27,655	4
2023-11-17	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,000	17.07	$17,070.00	19,036	4
2023-11-02	Raman-Tangella, Vidya	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	4,962	17.05	$84,602.10	35,931	4
2023-11-02	Kornwasser, Laizer	Officer	PRESIDENT, ENTERPRISE GROWTH	Direct	Sale	35,887	17.05	$611,873.35	44,907	4
2023-11-02	Waters, Michael Willem	Officer	CHIEF OPERATING OFFICER	Direct	Sale	5,482	17.05	$93,468.10	31,774	4
2023-10-31	Geshuri, Arnnon	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	365	16.28	$5,942.20	77,097	4
2023-10-17	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,000	18.74	$18,740.00	20,036	4
2023-09-25	Napolitano, Richard J	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	219	18.68	$4,090.92	9,457	4
2023-09-18	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,000	21.00	$21,000.00	21,036	4
2023-09-05	Verstraete, Stephany	Officer	CHIEF MARKETING OFFICER	Direct	Sale	506	22.89	$11,582.34	42,222	4
2023-09-05	Murthy, Mala	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,221	22.89	$73,728.69	46,907	4
2023-09-05	Napolitano, Richard J	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	649	22.89	$14,855.61	9,075	4
2023-09-05	Jensen, Claus Torp	Officer	CHIEF INNOVATION OFFICER	Direct	Sale	2,093	22.89	$47,908.77	15,853	4
2023-09-05	Turitz, Andrew	Officer	EVP, CORPORATE DEVELOPMENT	Direct	Sale	396	22.89	$9,064.44	24,718	4
2023-09-05	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	426	22.89	$9,751.14	22,036	4
2023-09-05	Geshuri, Arnnon	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	408	22.89	$9,339.12	76,401	4
2023-09-05	Vandervoort, Adam C	Officer	CHIEF LEGAL OFFICER, SECRETARY	Direct	Sale	961	22.89	$21,997.29	22,551	4
2023-09-05	Gorevic, Jason N	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	2,864	22.89	$65,556.96	598,996	4
2023-08-28	Geshuri, Arnnon	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	336	22.31	$7,496.16	75,630	4
2023-08-17	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,000	22.81	$22,810.00	21,283	4
2023-08-02	Waters, Michael Willem	Officer	CHIEF OPERATING OFFICER	Direct	Sale	19,340	27.03	$522,760.20	25,937	4
2023-08-02	Raman-Tangella, Vidya	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	5,215	27.03	$140,961.45	30,649	4
2023-07-27	Geshuri, Arnnon	Officer	CHIEF PEOPLE OFFICER	Direct	Sale	3,750	30.00	$112,500.00	75,966	4
2023-07-27	Gorevic, Jason N	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	10,000	30.03	$300,300.00	596,246	4
2023-07-26	Jensen, Claus Torp	Officer	CHIEF INNOVATION OFFICER	Direct	Sale	6,547	29.00	$189,863.00	13,096	4
2023-07-18	Jensen, Claus Torp	Officer	CHIEF INNOVATION OFFICER	Direct	Sale	6,547	27.00	$176,769.00	19,643	4
2023-07-17	Trencher, Daniel	Officer	CHIEF STRATEGY OFFICER	Direct	Sale	1,000	24.66	$24,660.00	22,283	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

78.41%

Inst. Shares: 140,449,778

Shares Outstanding: 179,122,268

2025-12-31

73.63%

Inst. Shares: 129,759,771

Shares Outstanding: 176,221,530

2025-09-30

68.37%

Inst. Shares: 120,961,692

Shares Outstanding: 176,934,781

2025-06-30

71.66%

Inst. Shares: 126,062,131

Shares Outstanding: 175,917,380

2025-03-31

70.77%

Inst. Shares: 123,244,703

Shares Outstanding: 174,154,128

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	140,449,778	179,122,268	78.41%
2025-12-31	129,759,771	176,221,530	73.63%
2025-09-30	120,961,692	176,934,781	68.37%
2025-06-30	126,062,131	175,917,380	71.66%
2025-03-31	123,244,703	174,154,128	70.77%
2024-12-31	124,567,733	170,564,088	73.03%
2024-09-30	121,976,163	171,496,282	71.12%
2024-06-30	135,575,984	170,229,583	79.64%
2024-03-31	121,321,397	167,730,746	72.33%
2023-12-31	120,415,939	164,578,219	73.17%
2023-09-30	116,308,209	165,119,379	70.44%
2023-06-30	120,271,780	164,171,372	73.26%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Teladoc Health, Inc. (TDOC) — SEC Financial Statements & Analysis

Teladoc Health, Inc. (TDOC) is a services-offices & clinics of doctors of medicine company, incorporated in DE. Teladoc Health, Inc. trades on TDOC: NYSE as: TDOC. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Teladoc Health, Inc. reported a -1.50% year-over-year revenue growth, a Gross Profit Margin of 69.29% (TTM), a Debt-to-Equity ratio of 1.10x, a Price-to-Sales (P/S) ratio of 0.39x (TTM), a Price-to-Book (P/B) ratio of 0.73 (TTM), at a market cap of $976.22M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -1.50%
Gross Profit Margin TTM: 69.29%
Debt To Equity: 1.10x
P/S TTM: 0.39x
P/B TTM: 0.73
Market Cap: $976.22M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Teladoc Health, Inc. in?

Teladoc Health, Inc. (TDOC) operates in the Services-Offices & Clinics of Doctors of Medicine industry.

What is TDOC's market cap?

Teladoc Health, Inc. (TDOC) has a market capitalization of $976.22M as of 2026-03-31.

What exchange does TDOC trade on?

Teladoc Health, Inc. (TDOC) trades on the TDOC: NYSE.

Where is Teladoc Health, Inc. incorporated?

Teladoc Health, Inc. is incorporated in DE.